Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 8, 2013, Pages 3035-3040

  Velusamy, Thirunavukkarasu ^a   Palanisamy, Nallasivam ^a,b,c   Kalyana Sundaram, Shanker ^b,d   Sahasrabuddhe, Anagh Anant ^a   Maher, Christopher A ^e   Robinson, Daniel R ^b   Bahler, David W ^f   Cornell, Timothy T ^a   Wilson, Thomas E ^a   Lim, Megan S ^a   Chinnaiyan, Arul M ^a,b,c   Elenitoba Johnson, Kojo S J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d BHARATHIDASAN UNIVERSITY   (India)

^e WASHINGTON UNIVERSITY   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

B lymphoid malignancy; Chimera splicing; Next generation sequencing; Serine threonine phosphatase PP1 beta catalytic subunit

Indexed keywords

PPP1CB PROTEIN; PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; YPEL5 PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; B CELL LEUKEMIA; CHIMERA; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUSION; GENE MUTATION; GENE SEQUENCE; GENE SILENCING; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA CHIMERA; SOUTHERN BLOTTING;

BLOTTING, SOUTHERN; CATALYTIC DOMAIN; CELL CYCLE PROTEINS; GENE FUSION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PROTEIN PHOSPHATASE 1; REAL-TIME POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 84874257263     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1214326110     Document Type: Article

References (49)

1. Rozman C, Montserrat E (1995) Chronic lymphocytic leukemia. N Engl J Med 333 (16):1052-1057.
2. Calin GA, et al. (2008) MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA 105 (13):5166-5171.
3. Klein U, et al. (2010) The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17 (1):28-40.
4. Liu Y, et al. (1997) Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene 15 (20):2463-2473.
5. Juliusson G, et al. (1990) Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323 (11):720-724.
6. Döhner H, et al. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343 (26):1910-1916.
7. Döhner H, et al. (1997) 11q deletions identify a new subset of B-cell chronic lym-phocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 89 (7):2516-2522.
8. Orchard JA, et al. (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 363 (9403):105-111.
9. Rassenti LZ, et al. (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 351 (9):893-901.
10. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999) Unmutated Ig V (H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94 (6):1848-1854.
11. Puente XS, et al. (2011) Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475 (7354):101-105.
12. Fabbri G, et al. (2011) Analysis of the chronic lymphocytic leukemia coding genome: Role of NOTCH1 mutational activation. J Exp Med 208 (7):1389-1401.
13. Matlin AJ, Clark F, Smith CW (2005) Understanding alternative splicing: Towards a cellular code. Nat Rev Mol Cell Biol 6 (5):386-398.
14. Castle JC, et al. (2008) Expression of 24, 426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. Nat Genet 40 (12):1416-1425.
15. Pajares MJ, et al. (2007) Alternative splicing: An emerging topic in molecular and clinical oncology. Lancet Oncol 8 (4):349-357.
16. Guerra E, et al. (2008) A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res 68 (19):8113-8121.
17. Cooper DL, Dougherty GJ (1995) To metastasize or not? Selection of CD44 splice sites. Nat Med 1 (7):635-637.
18. Christofk HR, et al. (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452 (7184):230-233.
19. Prinos P, et al. (2011) Alternative splicing of SYK regulates mitosis and cell survival. Nat Struct Mol Biol 18 (6):673-679.
20. Zhang Y, et al. (2012) Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation. Cancer Discov 2 (7):598-607.
21. Rickman DS, et al. (2009) SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. Cancer Res 69 (7):2734-2738.
22. Maher CA, et al. (2009) Transcriptome sequencing to detect gene fusions in cancer. Nature 458 (7234):97-101.
23. Maher CA, et al. (2009) Chimeric transcript discovery by paired-end transcriptome sequencing. Proc Natl Acad Sci USA 106 (30):12353-12358.
24. Melo JV, et al. (1986) Two new cell lines from B-prolymphocytic leukaemia: Characterization by morphology, immunological markers, karyotype and Ig gene rearrangement. Int J Cancer 38 (4):531-538.
25. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40 (12):1413-1415.
26. Wang ET, et al. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456 (7221):470-476.
27. Futreal PA, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4 (3):177-183.
28. Rowley JD (2001) Chromosome translocations: Dangerous liaisons revisited. Nat Rev Cancer 1 (3):245-250.
29. Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458 (7239):719-724.
30. Roxström-Lindquist K, Faye I (2001) The Drosophila gene Yippee reveals a novel family of putative zinc binding proteins highly conserved among eukaryotes. Insect Mol Biol 10 (1):77-86.
31. Hosono K, et al. (2010) YPEL5 protein of the YPEL gene family is involved in the cell cycle progression by interacting with two distinct proteins RanBPM and RanBP10. Genomics 96 (2):102-111.
32. Barker HM, Brewis ND, Street AJ, Spurr NK, Cohen PT (1994) Three genes for protein phosphatase 1 map to different human chromosomes: Sequence, expression and gene localisation of protein serine/threonine phosphatase 1 beta (PPP1CB). Biochim Biophys Acta 1220 (2):212-218.
33. Tournebize R, et al. (1997) Distinct roles of PP1 and PP2A-like phosphatases in control of microtubule dynamics during mitosis. EMBO J 16 (18):5537-5549.
34. Nekhai S, Jerebtsova M, Jackson A, Southerland W (2007) Regulation of HIV-1 transcription by protein phosphatase 1. Curr HIV Res 5 (1):3-9.
35. Bollen M, Stalmans W (1992) The structure, role, and regulation of type 1 protein phosphatases. Crit Rev Biochem Mol Biol 27 (3):227-281.
36. Liu L, et al. (2011) Consensus PP1 binding motifs regulate transcriptional corepression and alternative RNA splicing activities of the steroid receptor coregulators, p54nrb and PSF. Mol Endocrinol 25 (7):1197-1210.
37. Xie XJ, Huang W, Xue CZ, Wei Q (2009) The N-terminal domain influences the structure and property of protein phosphatase 1. Mol Cell Biochem 327 (1-2):241-246.
38. Schönthal AH (2001) Role of serine/threonine protein phosphatase 2A in cancer. Cancer Lett 170 (1):1-13.
39. Akiva P, et al. (2006) Transcription-mediated gene fusion in the human genome. Genome Res 16 (1):30-36.
40. Parra G, et al. (2006) Tandem chimerism as a means to increase protein complexity in the human genome. Genome Res 16 (1):37-44.
41. Kaye FJ (2009) Mutation-associated fusion cancer genes in solid tumors. Mol Cancer Ther 8 (6):1399-1408.
42. Fears S, et al. (1996) Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Proc Natl Acad Sci USA 93 (4):1642-1647.
43. Tolvanen M, et al. (2009) Interspliced transcription chimeras: Neglected pathological mechanism infiltrating gene accession queries? J Biomed Inform 42 (2):382-389.
44. Li H, Wang J, Mor G, Sklar J (2008) A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells. Science 321 (5894):1357-1361.
45. Makishima H, et al. (2012) Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 119 (14):3203-3210.
46. Rossi D, et al. (2012) Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 119 (2):521-529.
47. Quesada V, et al. (2012) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44 (1):47-52.
48. Kumar-Sinha C, Tomlins SA, Chinnaiyan AM (2008) Recurrent gene fusions in prostate cancer. Nat Rev Cancer 8 (7):497-511.
49. Tokino T, et al. (1991) Isolation and mapping of 62 new RFLP markers on human chromosome 11. Am J Hum Genet 48 (2):258-268.